Collegium Pharmaceutical Inc — 貸借対照表 (NASDAQ:COLL) | MetaTrader

チャート全体を表示

Financials

概要明細書統計

総資産 643.84 M692.08 M1.17 B1.14 B1.66 B1.66 B 負債合計 457.81 M489.15 M979.29 M947.88 M1.43 B1.36 B 純資産合計 186.03 M202.93 M194.84 M195.43 M228.84 M301.68 M 負債および純資産合計 643.84 M692.08 M1.17 B1.14 B1.66 B1.66 B 有利子負債合計 257.09 M249.99 M700.95 M667.17 M852.49 M809.33 M 純負債 92.47 M72.32 M535.49 M287.4 M602.34 M272.76 M

ニュース

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth - Slideshow (NASDAQ:COLL) 2026-03-24

Collegium Pharmaceuticals: Another M&A Episode Adds To An Intriguing Case (NASDAQ:COLL)

Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript

Collegium Pharmaceutical, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:COLL) 2026-03-01

Collegium Pharmaceutical (COLL) Reports Q4 Earnings: What Key Metrics Have to Say

Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates

Collegium Q4 2025 slides: ADHD drug surges despite earnings miss

【決算速報】コレギウム・ファーマシューティカル、売上高は予想を下回り、利益は予想を下回る結果に

Collegium Pharmaceutical earnings missed by $0.10, revenue fell short of estimates

Collegium Pharmaceutical決算発表控え、Jornay PMに注目集まる

Collegium Pharmaceutical earnings ahead: Jornay PM in focus

Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: Should You Buy?